Welcome to CDC stacks | Antimicrobial-drug use and methicillin-resistant Staphylococcus aureus. - 15077 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Antimicrobial-drug use and methicillin-resistant Staphylococcus aureus.
  • Published Date:
    2001 Jan-Feb
  • Source:
    Emerg Infect Dis. 7(1):161-163.
Filetype[PDF-44.63 KB]


Details:
No Related Documents.
You May Also Like:
  1. Methicillin-Resistant Staphylococcus aureus, Samoa, 2007–2008
    Personal Author:
    Alesana-Slater, James; Ritchie, Stephen R.; Heffernan, Helen; Camp, Tracy; Richardson, Alice; Herbison, Peter; Norris, Pauline;
    Published:
    Jun 2011
    Source:
    Emerg Infect Dis. 17(6):1023-1029.
    Description:
    Little is known about the epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in most Pacific Island nations. Relatively high rates of MRSA have been reported in Polynesian people living outside the Pacific Islands. To determine the pr...
    File Type:
    Filetype[PDF - 182.14 KB]
  2. Antimicrobial Drug Use and Methicillin-resistant Staphylococcus aureus, Aberdeen, 1996–2000
    Personal Author:
    Monnet, Dominique L.; MacKenzie, Fiona M.; López-Lozano, José María; Beyaert, Arielle; Camacho, Máximo; Wilson, Rachel; Stuart, David; Gould, Ian M.;
    Published:
    Aug 2004
    Source:
    Emerg Infect Dis. 10(8):1432-1441.
    Description:
    Similar to many hospitals worldwide, Aberdeen Royal Infirmary has had an outbreak of methicillin-resistant Staphylococcus aureus (MRSA). In this setting, the outbreak is attributable to two major clones. The relationships between antimicrobial use an...
    File Type:
    Filetype[PDF - 322.69 KB]
  3. Antimicrobial Drugs and Community-acquired Methicillin-Resistant Staphylococcus aureus, United Kingdom
    Personal Author:
    Schneider-Lindner, Verena; Delaney, J. A.; Dial, Sandra; Dascal, Andre; Suissa, Samy;
    Published:
    Jul 2007
    Source:
    Emerg Infect Dis. 13(7):994-1000.
    Description:
    We report results of a case-control study of the association between receipt of antimicrobial agents and diagnosis of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) in the United Kingdom. Eligible adults, selected from the Gene...
    File Type:
    Filetype[PDF - 276.09 KB]
  4. Methicillin-Resistant and -Susceptible Staphylococcus aureus Infections in Dogs
    Personal Author:
    Faires, Meredith C.; Traverse, Michelle; Tater, Kathy C.; Pearl, David L.; Weese, J. Scott;
    Published:
    Jan 2010
    Source:
    Emerg Infect Dis. 16(1):69-75.
    Description:
    Methicillin-resistant Staphylococcus aureus (MRSA) has become a pathogen of animals. To compare types of infections, clinical outcomes, and risk factors associated with MRSA in dogs with those associated with methicillin-susceptible Staphylococcus au...
    File Type:
    Filetype[PDF - 249.95 KB]
  5. Fluoroquinolones and Risk for Methicillin-Resistant Staphylococcus aureus, Canada
    Personal Author:
    LeBlanc, Louiselle; Pépin, Jacques; Toulouse, Krystel; Ouellette, Marie-France; Coulombe, Marie-Andrée; Corriveau, Marie-Pier; Alary, Marie-Eve;
    Published:
    Sep 2006
    Source:
    Emerg Infect Dis. 12(9):1398-1405.
    Description:
    Receipt of fluoroquinolones was the predominant risk factor for Clostridium difficile-associated disease (CDAD) during an epidemic in Quebec, Canada. To determine the role of antimicrobial drugs in facilitating healthcare-associated methicillin-resis...
    File Type:
    Filetype[PDF - 343.64 KB]